Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

HPV Vaccine Acceptance Among Mid-Adult Women

Daron G. Ferris, Jennifer L. Waller, Ashley Owen and Jozette Smith
The Journal of the American Board of Family Medicine January 2008, 21 (1) 31-37; DOI: https://doi.org/10.3122/jabfm.2008.01.070103
Daron G. Ferris
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L. Waller
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Owen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jozette Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Demographic Variables of Women in the Univariable Logistic Regression Models Wanting to Get the Human Papillomavirus Vaccine After Intervention

    Demographic VariablesLevelOdds Ratio95% CIWald χ2P
    Age (years)21.43.0015
    25–29 vs 55+11.393.58–6.22
    30–34 vs 55+8.82.53–30.57
    35–39 vs 55+10.152.88–35.83
    40–44 vs 55+12.373.20–47.83
    45–49 vs 55+6.681.86–23.99
    50–54 vs 55+4.631.32–16.26
    Family income ($)12.32.055
    10,000–19,000 vs >100,0009.602.41–38.22
    19,001–29,000 vs >100,0002.510.99–6.37
    29,001–39,000 vs >100,0002.931.13–7.62
    39,001–50,000 vs >100,0002.160.91–5.14
    50,001–100,000 vs >100,0001.950.89–4.24
    <10,000 vs >100,0002.290.72–7.30
    Medical insuranceYes vs no0.370.16–0.865.37.02
    Marital status10.75.03
    Married vs widowed0.930.18–4.77
    Divorced/separated vs widowed1.860.33–10.45
    Live with partner vs widowed2.500.35–18.03
    Single vs widowed2.160.41–11.46
    MonogamousYes vs no0.540.27–1.063.21.07
    Age at first sexual intercourse (years)0.890.82–0.976.81.009
    Vaginal sexYes vs no2.351.02–5.374.06.04
    Birth control4.50.11
    Barrier vs abstinence1.250.35–4.94
    Non-barrier vs abstinence0.600.18–2.04
    STI statusAny STI vs no STI2.101.18–3.746.35.01
    Abnormal Pap test6.80.03
    DK vs no1.390.48–4.06
    Yes vs no2.061.20–3.57
    Age at first Pap test0.930.85–1.013.23.07
    Have had a mammogramYes vs no0.490.30–0.817.91.005
    • Referent groups are listed second for all levels.

    • HPV, human papillomavirus; STI, sexually transmitted infection; DK, does not know if they have ever had an abnormal Pap test.

    • View popup
    Table 2.

    Knowledge and Behaviors Before Intervention of Women in Univariable Logistic Regression Models Wanting to Get the Human Papillomavirus Vaccine After Intervention

    VariablesLevelsOdds Ratio95% CIWald χ2P
    Important to get vaccines5.63.06
    Important vs not important4.481.05–19.14
    Neutral vs not important2.500.56–11.23
    HPV causes cancerYes vs no2.471.13–5.435.10.02
    At risk for HPVYes vs no2.211.04–4.684.28.04
    Know what HPV vaccine is forYes vs no1.940.93–4.033.14.08
    Important to get HPV vaccine20.81<.0001
    Important vs not important40.618.15–202.42
    Neutral vs not important19.804.09–95.96
    • HPV, human papillomavirus.

    • View popup
    Table 3.

    Knowledge and Behaviors After Intervention in Women in Univariable Logistic Regression Models Wanting to Get the Human Papillomavirus Vaccine After Intervention

    VariableLevelsOdds Ratio95% CIWald χ2P
    Intervention information changed mind about     HPV vaccineYes vs no3.522.06–6.0021.35<.0001
    At risk for HPVYes vs no25.8110.07–66.1745.82<.0001
    Would get any vaccine27.87<.0001
    No vaccine vs STI vaccine0.120.04–0.32
    Other vaccine vs STI vaccine0.070.02–0.32
    Important for partner to get HPV vaccine77.04<.0001
    Important vs not important120.1740.83–353.68
    Neutral vs not important11.025.01–24.24
    Important for children to get HPV vaccine38.48<.0001
    Important vs not important18.193.98–83.19
    Neutral vs not important4.060.86–19.27
    Pap smears important8.98.01
    Important vs not important1.770.11–28.55
    Neutral vs not important0.250.01–5.26
    Too late to get HPV vaccineYes vs no0.140.07–0.2731.13<.0001
    More inclined to get HPV vaccine if…
        Recommended by family memberYes vs no4.271.84–9.8811.44.0007
        Recommended by nurseYes vs no3.511.74–7.0712.33.0004
        Paid for by insuranceYes vs no3.221.97–5.2521.83<.0001
    Amount would pay for HPV vaccine to prevent     cervical cancer and genital warts ($)15.55.004
    101–200 vs none6.232.17–17.90
    201+ vs none4.111.72–9.80
    51–100 vs none3.761.63–8.70
    <50 vs none2.591.14–5.86
    HPV causes cervical cancerYes vs no2.201.30–3.728.71.003
    HPV can prevent genital wartsYes vs no1.760.95–3.283.19.07
    • HPV, human papillomavirus; STI, sexually transmitted infection.

    • View popup
    Table 4.

    Final Multivariable Logistic Regression Models for Wanting to Get the Human Papillomavirus Vaccine After Intervention: Demographics, Knowledge, and Behaviors Before Intervention and Knowledge and Behaviors After Intervention

    VariablesLevelOdds Ratio95% CIWald χ 2P
    Demographic
        Age (years)21.660.001
    25–29 vs 55+11.623.60–37.51
    30–34 vs 55+8.892.50–31.61
    35–39 vs 55+9.622.66–34.79
    40–44 vs 55+11.632.90–46.62
    45–49 vs 55+7.532.05–27.68
    50–54 vs 55+4.001.11–14.39
        MonogamousYes vs no0.460.21–1.003.850.05
        Abnormal Pap test6.840.03
    DK vs no0.790.24–2.55
    Yes vs no2.151.18–3.92
    Knowledge and Behaviors Pre-Intervention
        HPV causes cancerYes vs no2.391.08–5.304.590.03
        At risk for HPVYes vs no2.141.00–4.573.880.05
    Knowledge and Behaviors Post-Intervention
        Would get any vaccine7.320.03
    No vaccine vs STI vaccine0.260.07–0.92
    Other vaccine vs STI vaccine0.220.04–1.10
        Important for partner to get HPV     vaccine47.92<0.0001
    Important vs not important25.209.66–65.72
    Neutral vs not important14.445.83–35.79
        Important for child to get HPV vaccine10.460.005
    Important vs not important3.540.51–24.56
    Neutral vs not important1.040.15–7.45
        Too late to get HPV vaccineYes vs no0.180.08–0.4414.760.0001
    • HPV, human papillomavirus; STI, sexually transmitted infection; DK, does not know if they havevever had an abnormal Pap test.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 21 (1)
The Journal of the American Board of Family Medicine
Vol. 21, Issue 1
January-February 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
HPV Vaccine Acceptance Among Mid-Adult Women
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
HPV Vaccine Acceptance Among Mid-Adult Women
Daron G. Ferris, Jennifer L. Waller, Ashley Owen, Jozette Smith
The Journal of the American Board of Family Medicine Jan 2008, 21 (1) 31-37; DOI: 10.3122/jabfm.2008.01.070103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
HPV Vaccine Acceptance Among Mid-Adult Women
Daron G. Ferris, Jennifer L. Waller, Ashley Owen, Jozette Smith
The Journal of the American Board of Family Medicine Jan 2008, 21 (1) 31-37; DOI: 10.3122/jabfm.2008.01.070103
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Parental Acceptance of a Mandatory Human Papillomavirus (HPV) Vaccination Program
  • North American Primary Care Research Group President's Award
  • Google Scholar

More in this TOC Section

  • A Pilot Comparison of Clinical Data Collection Methods Using Paper, Electronic Health Record Prompt, and a Smartphone Application
  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
Show more Original Research

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire